155 related articles for article (PubMed ID: 30352411)
1. 1α,25-dihydroxyvitamin D3 promotes osseointegration of titanium implant via downregulating AGEs/RAGE pathway in T2DM.
Jia T; Wang YN; Zhang D; Xu X
Endocr Connect; 2018 Sep; 7(11):1186-95. PubMed ID: 30352411
[TBL] [Abstract][Full Text] [Related]
2. Silibinin-modified Hydroxyapatite coating promotes the osseointegration of titanium rods by activation SIRT1/SOD2 signaling pathway in diabetic rats.
Tao ZS; Wang HS; Li TL; Wei S
J Mater Sci Mater Med; 2022 Sep; 33(9):62. PubMed ID: 36057883
[TBL] [Abstract][Full Text] [Related]
3. Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway.
Cheng YZ; Yang SL; Wang JY; Ye M; Zhuo XY; Wang LT; Chen H; Zhang H; Yang L
Life Sci; 2018 Jul; 205():184-192. PubMed ID: 29702126
[TBL] [Abstract][Full Text] [Related]
4. Methylglyoxal - an advanced glycation end products (AGEs) precursor - Inhibits differentiation of human MSC-derived osteoblasts in vitro independently of receptor for AGEs (RAGE).
Waqas K; Muller M; Koedam M; El Kadi Y; Zillikens MC; van der Eerden BCJ
Bone; 2022 Nov; 164():116526. PubMed ID: 35995334
[TBL] [Abstract][Full Text] [Related]
5. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
Phimphilai M; Pothacharoen P; Kongtawelert P
Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
[TBL] [Abstract][Full Text] [Related]
6. Blockade of receptors of advanced glycation end products ameliorates diabetic osteogenesis of adipose-derived stem cells through DNA methylation and Wnt signalling pathway.
Zhang M; Li Y; Rao P; Huang K; Luo D; Cai X; Xiao J
Cell Prolif; 2018 Oct; 51(5):e12471. PubMed ID: 30014569
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 3A delivered by a rapidly polymerizing click hydrogel overcomes impaired implant osseointegration in a rat type 2 diabetes model.
Deng J; Cohen DJ; Sabalewski EL; Van Duyn C; Wilson DS; Schwartz Z; Boyan BD
Acta Biomater; 2023 Feb; 157():236-251. PubMed ID: 36435442
[TBL] [Abstract][Full Text] [Related]
8. Effects of metformin on the osteogenesis of alveolar BMSCs from diabetic patients and implant osseointegration in rats.
Sun R; Liang C; Sun Y; Xu Y; Geng W; Li J
Oral Dis; 2022 May; 28(4):1170-1180. PubMed ID: 33606350
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin improves the osteointegration of titanium implant under diabetic conditions by reversing mitochondrial dysfunction via the AMPK pathway in vivo and in vitro.
Hu XF; Wang L; Lu YZ; Xiang G; Wu ZX; Yan YB; Zhang Y; Zhao X; Zang Y; Shi L; Lei W; Feng YF
Acta Biomater; 2017 Oct; 61():233-248. PubMed ID: 28624657
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D3 and insulin combined treatment promotes titanium implant osseointegration in diabetes mellitus rats.
Wu YY; Yu T; Yang XY; Li F; Ma L; Yang Y; Liu XG; Wang YY; Gong P
Bone; 2013 Jan; 52(1):1-8. PubMed ID: 22985888
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
[TBL] [Abstract][Full Text] [Related]
12. Sandblasted/Acid-Etched Titanium Surface Modified with Calcium Phytate Enhances Bone Regeneration in a High-Glucose Microenvironment by Regulating Reactive Oxygen Species and Cell Senescence.
Dong S; Zhao T; Wu W; Zhang Z; Wu J; Cai K; Li G; Lv J; Zhou H; Tang C
ACS Biomater Sci Eng; 2023 Aug; 9(8):4720-4734. PubMed ID: 37491189
[TBL] [Abstract][Full Text] [Related]
13. Local treatment with Sema3a could promote the osseointegration of hydroxyapatite coated titanium rod in diabetic rats.
Wang Z; Wei S
J Biomater Appl; 2022 May; 36(10):1775-1785. PubMed ID: 35225049
[TBL] [Abstract][Full Text] [Related]
14. Cinaciguat in combination with insulin induces a favorable effect on implant osseointegration in type 2 diabetic rats.
Jia T; Wang YN; Zhang J; Hao X; Zhang D; Xu X
Biomed Pharmacother; 2019 Oct; 118():109216. PubMed ID: 31319371
[TBL] [Abstract][Full Text] [Related]
15. Morroniside attenuates high glucose-induced BMSC dysfunction by regulating the Glo1/AGE/RAGE axis.
Sun Y; Zhu Y; Liu X; Chai Y; Xu J
Cell Prolif; 2020 Aug; 53(8):e12866. PubMed ID: 32643284
[TBL] [Abstract][Full Text] [Related]
16. Genipin and insulin combined treatment improves implant osseointegration in type 2 diabetic rats.
Zhang J; Wang YN; Jia T; Huang H; Zhang D; Xu X
J Orthop Surg Res; 2021 Jan; 16(1):59. PubMed ID: 33446235
[TBL] [Abstract][Full Text] [Related]
17. Effect and mechanism of propranolol on promoting osteogenic differentiation and early implant osseointegration.
Wu Y; Zhang Q; Zhao B; Wang X
Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34414453
[TBL] [Abstract][Full Text] [Related]
18. Osseointegration of chitosan coated porous titanium alloy implant by reactive oxygen species-mediated activation of the PI3K/AKT pathway under diabetic conditions.
Li X; Ma XY; Feng YF; Ma ZS; Wang J; Ma TC; Qi W; Lei W; Wang L
Biomaterials; 2015 Jan; 36():44-54. PubMed ID: 25308520
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HMGB1 Promotes Osseointegration under Hyperglycemic Condition through Improvement of BMSC Dysfunction.
Liu B; Gan X; Zhao Y; Yu H; Gao J; Yu H
Oxid Med Cell Longev; 2019; 2019():1703709. PubMed ID: 31929852
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
Kume S; Kato S; Yamagishi S; Inagaki Y; Ueda S; Arima N; Okawa T; Kojiro M; Nagata K
J Bone Miner Res; 2005 Sep; 20(9):1647-58. PubMed ID: 16059636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
